Key facts
- This page summarizes Adam Taich's Form 4 filing for 10x Genomics, Inc. (TXG).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 27 May 2026, 17:55.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
Sale
Additional SEC filing notes
Footnote F1
The shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units.